Use: Labeled indications
- Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
Full indications and usage US FDA label
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions take every 4 to 6 hours, or as directed by a doctor adults and children 12 years and over 1 tablet. Do not exceed 6 tablets in 24 hours. children 6 to under 12 years 1/2 tablet (break tablet in half). Do not exceed 3 whole tablets in 24 hours. children under 6 years do not use
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Syrup: 2 mg/5 mL, 2.5 mg/5 mL
- Tablet: 4 mg, 5 mg
- Solution for injection: 10 mg/mL
Registered products in the Philippines
27 products registered with the Food and Drug Administration (FDA) Philippines list Chlorphenamine as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Chlorpheniramine Maleate (4 products). Products registered under these spellings are included in the table and marked.
All registered products27
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Aller CMChlorphenamine Maleate | Tablet 4mgAmber bottle x 100's (Bottle x 100's) | Rx | Philmed Laboratories Inc.Philippines | — | DR-X7078 | Jan 15, 2030 | |
AllermaxChlorphenamine Maleate | 2 mg/5 mL SyrupAmber Glass Bottle x 30 mL, 60 mL and 120 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-5491 | May 24, 2030 | |
AllermaxChlorphenamine Maleate | 4 mg TabletAlu-Clear PVC Blister Pack x 20's (Box of 100's) | Rx | Drugmaker’s Laboratories, Inc.Philippines | — | DRP-5201 | Mar 28, 2030 | |
2 mg/ 5 mL SyrupAmber Glass Bottle x 60 mL Box of 1's | Rx | PASCUAL LABORATORIES, INC.Philippines | Trader: ADP PHARMA CORPORATION | DR-XY2450 | May 25, 2029 | ||
AntaminChlorphenamine Maleate | 4 mg TabletStrip Foil x 10's (Box of 100's) | Rx | Pascual Laboratories, Inc.Philippines | Trader: ADP Pharma Corporation | DR-2359 | Apr 5, 2027 | |
BarominicChlorphenamine Maleate | 2.5 mg/5 mL SyrupAmber Glas Bottle x 60 mL (Box of 1's) | Rx | Am-Europharma CorporationPhilippines | — | DRP-7987 | Dec 6, 2031 | |
5 mg TabletBlister Pack X 10's & 20's (Box of 100's) | Rx | Am-Europharma CorporationPhilippines | Eurocare Pharma, Inc | DRP-4062 | Jun 14, 2030 | ||
ChlorsaphChlorphenamine maleate | 2.5 mg/5 mL Syrup (Orange Flavor)PET Round Amber Bottle x 60 mL and 120 mL (Box of 1's) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | Nelpa Lifesciences Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14453 | Sep 6, 2028 | |
HistablocChlorphenamine maleate | 2 mg/5 mL SyrupRound Amber Bottle x 60 mL (Box of 1's) | Rx | Interphil Laboratories, Inc.Philippines | — | DRP-8253 | Jul 15, 2029 | |
HistapenChlorphenamine Maleate | 4mg TabletBlister Pack x 20's Box of 100's | Rx | Lumar Pharmaceutical Laboratory, Inc.Philippines | TGP Pharma Inc. | DRP-2341-01 | Jun 5, 2027 | |
HistapenChlorphenamine Maleate | 5 mg TabletBlister pack x 20's (Box of 100's) | Rx | Am-Europharma CorporationPhilippines | TGP Pharma Inc. | DRP-4062-01 | Apr 5, 2031 | |
LorecareChlorphenamine maleate | 10 mg/mL Solution for Injection (I.M./I.V./S.C.)USP Type I Amber Colored Glass Ampoule in 1 mL (net content). (Box of 10's) | Rx | Suicheng Pharmaceutical Co., Ltd.China | Aglobal Care, Inc. | DR-XY45961 | May 8, 2029 | |
MervilarChlorphenamine | 2.5mg/5mL SyrupAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-2340 | Jun 13, 2031 | |
MervilarChlorphenamine Maleate | 4mg TabletBlister Pack x 20's (Box of 100's) | Rx | Lumar Pharmaceutical Laboratory, Inc.Philippines | — | DRP-2341 | Jun 5, 2027 | |
NoneChlorphenamine Maleate | 2 mg/5 mL SyrupAmber glass bottle x 60mL (Box of 1's) | Rx | Drugmaker's Laboratories Inc.Philippines | TGP Pharma Inc | DRP-5491-01 | Apr 5, 2031 | |
NoneChlorphenamine Maleate | 4 mg TabletAlu-Clear PVC Blister Pack x 20's (Box of 100's) | Rx | Drugmakers Laboratories Inc.Philippines | TGP Pharma Inc. | DRP-5201-01 | Mar 28, 2030 | |
5 mg TabletBlister Pack x 10's and 20's (Box of 100's) | Rx | AM-Europharma CorporationPhilippines | RiteMED Phils., Inc. | DRP-4062-02 | Jun 13, 2031 | ||
2.5 mg/5 mL SyrupBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-3414 | Sep 2, 2029 | ||
RiphenChlorphenamine maleate | 2 mg / 5 mL SyrupAmber Bottle with printed aluminum cap x 60 mL Not Applicable | Rx | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-2480 | Mar 14, 2031 | |
RiphenChlorphenamine Maleate | 4 mg TabletAlu/PVC Blister Pack x 20's (Box of 100's) | Rx | Diamond Laboratories, Inc.Philippines | Rilem Pharma Corp. | DRP-7812 | Jan 2, 2032 | |
RosamineChlorphenamine Maleate | 2.5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | Rx | LEJAL LABORATORIES INC.Philippines | — | DR-XY8494 | Jul 13, 2028 | |
SaphelormineChlorphenamine maleate | 2 mg/5 mL Syrup (Orange Flavor)PET Round Amber Bottle x 60 mL and 120 mL (Box of 1's) | OTC | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14506 | Sep 26, 2028 | |
SaphelormineChlorphenamine maleate | 2.5 mg/5 mL Syrup (Orange Flavor)PET Round Amber Bottle x 60 mL and 120 mL (Box of 1's) | OTC | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14507 | Sep 26, 2028 | |
SinustanChlorphenamine Maleate | 10 mg/mL Solution for Injection (IM/IV/SC)Type I Amber Colored Glass Ampoule x 1mL in a plastic tray (Box of 10's) | Rx | Zhejiang Ruixin Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY42524 | Sep 3, 2028 | |
ValemineChlorphenamine maleate | 2 mg/5 mL SyrupAmber Bottle with printed Aluminum cap x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Philippines, Inc. | DR-XY27057 | Jul 5, 2031 | |
ValemineChlorphenamine Maleate | 4 mg TabletBlister Pack x 20's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY25837 | Jan 21, 2030 | |
(no brand name)Chlorphenamine Maleate | 10mg/mL Solution for Injection (IM/IV/SC)Amber Glass Ampoule x 1mL (Box of 50's) | Rx | Atlantic Laboratories Corporation LimitedThailand | Phil Pharmawealth, Inc. | DR-XY27931 | Oct 11, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings Do not use to make a child sleepy. Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery excitability may occur, especially in children If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Chlorphenamine (Chlorpheniramine) 4 mg Tablet | ₱0.38–₱0.97Reference ₱0.40 | per tablet | DPRI procurement range |
| Chlorphenamine (Chlorpheniramine) 10 mg/mL,1 mL Ampule | ₱10.40–₱12.00Reference ₱11.29 | per ampule | DPRI procurement range |
| 2.5 mg/5 mL (as maleate) syrup in 60 mL | ₱37.75 | per unit | PhilHealth GAMOT fixed fee |
| 4 mg (as maleate) tablet | ₱4.00 | per tablet | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Chlorphenamine (Chlopheniramine) (as maleate) |
| PNF listing | Oral: 4 mg tablet |
| PNF listing | Oral: 2.5 mg/5 mL syrup, 60 mL |
| PNF listing | Inj.: 10 mg/mL, 1 mL ampul/vial (IM, IV) |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
| PhilHealth YAKAP (formerly Konsulta) | Yes |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Allergy Relief · Chain Drug Marketing Association, Inc. [US FDA-approved label, version 4, September 30, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68bda134-0a6c-431c-be2e-cbcfcfb35bd7
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .
